These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20609855)

  • 41. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.
    Xu H; Banerjee A; Dilulio NA; Fairchild RL
    J Immunol; 1997 May; 158(10):4721-8. PubMed ID: 9144485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction and regulation of T-cell priming for contact hypersensitivity.
    Gorbachev AV; Fairchild RL
    Crit Rev Immunol; 2001; 21(5):451-72. PubMed ID: 11942559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in the understanding of hypersensitivity reactions to drugs.
    Thong B; Blanca M
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):291-2. PubMed ID: 19568004
    [No Abstract]   [Full Text] [Related]  

  • 48. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs.
    Cornejo-Garcia JA; Fernandez TD; Torres MJ; Carballo M; Hernan I; Antunez C; Blanca M; Mayorga C
    Allergy; 2007 Dec; 62(12):1429-38. PubMed ID: 17983377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial: T cell effector responses to drugs.
    Blanca M
    Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):287-8. PubMed ID: 18596582
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunological mechanisms in the reaction between drugs and the skin.
    Turk JL
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():58-61. PubMed ID: 134047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interaction between CD4 and MHC class II molecules and its effect on T cell function.
    Vignali DA
    Behring Inst Mitt; 1994 Jul; (94):133-47. PubMed ID: 7998907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deciphering the immune pathomechanism of cutaneous drug reactions.
    Pichler WJ
    Allergy; 2002; 57 Suppl 72():34-6. PubMed ID: 12144552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune pathomechanism and classification of drug hypersensitivity.
    Pichler WJ
    Allergy; 2019 Aug; 74(8):1457-1471. PubMed ID: 30843233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive drug allergy testing: an alternative viewpoint.
    Pichler WJ
    Toxicology; 2001 Feb; 158(1-2):31-41. PubMed ID: 11164990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.
    Yun J; Adam J; Yerly D; Pichler WJ
    Allergy; 2012 Nov; 67(11):1338-46. PubMed ID: 22943588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular aspects of drug recognition by specific T cells.
    Britschgi M; von Greyerz S; Burkhart C; Pichler WJ
    Curr Drug Targets; 2003 Jan; 4(1):1-11. PubMed ID: 12528985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug hypersensitivity.
    Yawalkar N
    Acta Clin Belg; 2009; 64(6):529-33. PubMed ID: 20101877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms.
    Pichler WJ; Hausmann O
    Int Arch Allergy Immunol; 2016; 171(3-4):166-179. PubMed ID: 27960170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept.
    Pichler WJ
    Curr Opin Allergy Clin Immunol; 2002 Aug; 2(4):301-5. PubMed ID: 12130944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.